Introduction
============

During inflammation, the activation of phagocytes both in vivo and in vitro can result in the generation and release of superoxide anion radical and hydrogen peroxide (respiratory burst) as well as in the secretion of myeloperoxidase. Myeloperoxidase, which is highly expressed in neutrophils, reacts with hydrogen peroxide in the presence of physiological chloride concentrations, catalyzing the formation of hypochlorous acid/hypochlorite (HOCl/OCl^−^). This short-lived and diffusible oxidant plays a major role as a potent microbicidal agent in the immune defense against invading microbial pathogens.[@R1] Upon phagocyte activation, HOCl concentrations can increase at least up to 340 µM ^2^. However, excessive or permanent HOCl production may cause tissue damage, since HOCl can participate in secondary non-enzymatic reactions, including oxidation and/or chlorination. HOCl can react with a variety of target compounds, for instance with unsaturated fatty acids to form chlorohydrins or with amines resulting in reactive chloramines, which, in turn, are powerful oxidants.[@R3] Of note, lysine-derived chloramines can generate nitrogen- and, subsequently, carbon-centered radicals, which may amplify the formation of oxygen radicals.[@R4] HOCl-modified target compounds are present during early and acute stages of inflammation.[@R1]^,^[@R5]^,^[@R6] This suggests an implication of the myeloperoxidase-HOCl pathway in the pathogenesis of various inflammatory diseases, such as atherosclerosis or coronary heart disease.[@R7] Thereby, a number of studies have reported that HOCl may activate the apoptotic machinery of cells involved in the initiation and progression of disease.[@R8]^-^[@R10]

Establishing the mode(s) of action underlying HOCl-mediated cytotoxicity is thus important for two distinct reasons: (1) the mechanistic disclosure of HOCl's microbicidal effects and (2) the understanding of deleterious HOCl-modifications in human proteins. In order to examine the lethal mechanism(s) triggered by HOCl, we used the budding yeast *Saccharomyces cerevisiae*. On the one hand, HOCl has been previously reported to elicit cytotoxic effects against *S. cerevisiae*,[@R11]^-^[@R13] thus allowing to investigate antifungal HOCl activities. On the other hand, *S. cerevisiae* also represents a well-established model organism to explore the core machinery executing programmed cell death (PCD), which, over the past decade, has been demonstrated to be phylogenetically conserved.[@R14]^-^[@R16] In fact, the yeast genome encodes orthologs of crucial mammalian apoptosis and necrosis regulators, including one caspase (Yca1p), the serine protease OMI (Nma111p), cathepsin D (Pep4p), endonuclease G (Nuc1p) or BH3-only proteins (Ybh3p).[@R17]^-^[@R22] Additionally, yeast PCD is connected to complex PCD features reminiscent of mammalian cells, such as mitochondrial fragmentation, mitochondrial outer membrane permeabilization or histone H2B phosphorylation.[@R23]^-^[@R25] Furthermore, *S. cerevisiae* has been successfully used to explore cell death connections to, e.g., lipids or the cell cycle, as well as to investigate lethal pathways underlying pharmacologically relevant agents such as the anticancer drug cisplatin.[@R26]^-^[@R30] Of note, two physiological scenarios deriving in yeast PCD, chronological and replicative aging, have been effectively applied to investigate phylogenetically conserved aging pathways of postmitotic mammalian cells and stem cells, respectively.[@R31]^-^[@R33] For instance, the naturally occurring polyamine spermidine has been shown to exert anti-aging effects that share a common mechanism in yeast, flies and nematodes.[@R34]^,^[@R35] Interestingly, recent evidence suggests that also the broader functional realm of spermidine (e.g., which includes, e.g., roles in reproduction) can be modeled in budding yeast.[@R36]^,^[@R37] Altogether, this functional correspondence allows using *S. cerevisiae* to analyze lethal pathways and scenarios of higher eukaryotes including those elicited in mammalian cells.

In this study, we aimed at characterizing the cytotoxic effects of HOCl in *S. cerevisiae* and at identifying corresponding molecular executors. We show that HOCl-mediated cell death in *S. cerevisiae* is mainly of apoptotic origin and results in elevated levels of reactive oxygen species (ROS) and formation of HOCl-modified proteins. Thereby, the protease Kex1p appears to mediate HOCl-induced lethality, since its absence enhances cell viability and decreases levels of ROS as well as formation of HOCl-modified epitopes upon challenge with lethal doses of HOCl.

Results
=======

HOCl induces ROS-mediated cell death
------------------------------------

HOCl can exert cytotoxicity on both microbial and human cells. In order to explore both scenarios, we assessed the impact of HOCl on the budding yeast *S. cerevisiae*, which combines both being a microorganism and an established eukaryotic cell death model. Application of submillimolar concentrations of HOCl to exponentially growing yeast cells resulted in a significant and dose-dependent decrease of clonogenic survival ([Fig. 1A](#F1){ref-type="fig"}). At 285 and 300 µM HOCl, survival rates were 30 and 60% lower compared with the untreated controls ([Fig. 1A](#F1){ref-type="fig"}). This concentration range is similar to that calculated at sites of acute inflammation, where HOCl levels can increase up to 340 µM or even higher.[@R2] The determined loss of survival was paralleled by an increased production of ROS ([Fig. 1B](#F1){ref-type="fig"}), as indicated by the enhanced superoxide-driven conversion of non-fluorescent dihydroethidium (DHE) into fluorescent ethidium (Eth). Conversely, the pre-treatment of yeast cells with the ROS-scavengers glutathione and N-acetyl-cysteine maintained cell viability ([Fig. 1C](#F1){ref-type="fig"}) and prevented ROS accumulation ([Fig. 1D](#F1){ref-type="fig"}) upon HOCl challenge. Altogether, these results suggest that HOCl-triggered yeast cell death is mediated by ROS. In fact, it is likely that the sources of these ROS are mitochondria, since cells devoid of mitochondrial DNA (ρ^0^) are protected against HOCl-inflicted ROS production and cell death ([**Fig. S2A and B**](#SUP1){ref-type="supplementary-material"}).

![**Figure 1.** HOCl induces apoptotic cell death and specific protein modifications in *S. cerevisiae*. (**A**) Survival determined by clonogenicity of wild type cells after treatment with or without different concentrations of HOCl for 16 h. Data represent means ± s.e.m. (n = 12; \*\*\*, p \< 0.001). Survival was normalized to the untreated control. (**B**) ROS production of wild type cells shown in (**A**) as determined via DHE→Ethidium conversion using a fluorescence plate reader. Data represent means ± s.e.m. (n = 12; \*\*, p \< 0.01; \*\*\*, p \< 0.001). RFU, relative fluorescence unit. (**C and D**) Survival normalized to the untreated control (**C**) and ROS production (**D**) of wild type cells grown to exponential phase in the absence (control) or presence of 5 mM L-glutathione (GSH) or N-acetyl-[l]{.smallcaps}-cysteine (NAC) and subsequent treatment with or without 300 µM HOCl for 16 h as determined via clonogenicity (**C**) and DHE→Ethidium conversion using a fluorescence plate reader (**D**). Data represent means ± s.e.m. (n = 9; \*\*\*, p \< 0.001). RFU, relative fluorescence unit. (**E**) Phosphatidylserine externalization and loss of plasma membrane integrity of wild type cells after treatment with or without 270 µM HOCl for 16 h as determined using Annexin V/PI costaining and quantified via flow cytometry. Data indicate means ± s.e.m. (n = 6; \*\*\*, p \< 0.001). In each experiment 30,000 cells were evaluated. (**F**) DNA fragmentation of wild type cells after treatment with or without 270 µM HOCl for 16 h as determined via TUNEL staining and quantified via flow cytometry. Data indicate means ± s.e.m. (n = 6; \*\*\*, p \< 0.001). In each experiment 30,000 cells were evaluated.](cc-12-1704-g1){#F1}

It should be noted that there exists a quantitative difference between the survival levels upon HOCl treatment (300 µM) displayed in [Figure 1A](#F1){ref-type="fig"} vs. [Figure 1C](#F1){ref-type="fig"} (compare also [Fig. 2A--C](#F2){ref-type="fig"}). In fact, the degree of HOCl cytotoxicity at a given concentration differed depending on the batch of SMD growth medium used, though a priori all batches should have had exactly the same composition. Conversely, the range of concentrations in which HOCl killed wild type yeast cells at a comparable quantitative level varied between 260--300 µM, depending on the specific medium batch (note the use of different HOCl concentrations in [Fig. 1E and F](#F1){ref-type="fig"} vs. [Fig. 2E and F](#F2){ref-type="fig"}). Within a batch and at a determined concentration, the qualitative and quantitative results remained stable. For this reason, we assume that some compound(s) in the medium cross-reacting with HOCl and slightly modifying its potency to kill yeast cells are sensitive to external factors that are difficult to control and might slightly differ from medium preparation to preparation. One of these compounds might be photosensitive, since the medium needed to be kept in the dark to maintain constant HOCl cytotoxic performance within one medium batch over time. Interestingly, it has been reported that ammonium ions, which are a component in the medium used in this study, influence HOCl cytotoxicity.[@R38] Also, moderate modifications in extracellular pH interfere with HOCl apoptotic induction.[@R39] These examples suggest that, indeed, slight changes in media composition may have an impact on the quantitative extension of HOCl-induced cytotoxicity, and that the corresponding concentration range must be assessed prior to the use of a specific medium batch. However, the actual nature of the described medium batch-dependent variance remains undetermined.

![**Figure 2.** The protease Kex1p is involved in HOCl-induced cytotoxicity. (**A and B**) Survival (**A**) and ROS production (**B**) of wild type, Δ*yca1*, Δ*nuc1*, Δ*ndi1*, Δ*kex1*, Δ*nma111*, Δ*aif1*, Δ*pep4*, Δ*cpl1* and Δ*ybh3* cells after treatment with or without 300 µM HOCl for 16 h as determined via clonogenicity (**A**) and DHE→Ethidium conversion (**B**), respectively. Survival (**A**) was normalized to the untreated control. Experiments in (**B**) were quantified using a fluorescence plate reader. Data represent means ± s.e.m. (n = 8 -- 16). The dashed line draws the survival (**A**) and ethidium fluorescence (**B**) levels of the HOCl-treated wild type, respectively. RFU, relative fluorescence unit. (**C--F**) Survival (**C**), ROS production (**D**), phosphatidylserine externalization (**E**), loss of membrane integrity (**E**) and apoptotic DNA fragmentation (**F**) of wild type and Δ*kex1* cells after treatment with or without 300 µM HOCl for 16 h as determined via clonogenicity (**C**), DHE→Ethidium conversion (**D**), Annexin V/PI co-staining (**E**) and TUNEL staining (**F**). Data represent means ± s.e.m. (n = 8; \*\*\*, p \< 0.001). Survival (**A**) was normalized to the untreated control. In each experiment for (**D--F**), 30,000 cells were evaluated using flow cytometry. (**G**) Fluorescence intensity of wild type and Δ*kex1* cells after treatment with or without 300 µM HOCl for 16 h and subsequent immunofluorescence (IF) staining using mAb 2D10G9 as a primary antibody and quantified using a fluorescence plate reader. Data represent means ± s.e.m. (n = 9; \*\*, p \< 0.01). RFU, relative fluorescence unit.](cc-12-1704-g2){#F2}

HOCl treatment results in specific protein modifications
--------------------------------------------------------

In mammalian cells, HOCl cytotoxicity is accompanied by distinct protein oxidation products. Using a specific antibody that selectively recognizes HOCl-modified epitopes,[@R40] immunocytochemistry revealed increased staining in HOCl-treated wild type cells as compared with the untreated control ([Fig. 2G](#F2){ref-type="fig"}). Omission of the primary antibody or its replacement with an IgG isotype control eliminated all staining, demonstrating that the observed staining was not due to a non-specific effect (data not shown). Also, competition with authentic HOCl-modified albumin (30 µg/ml) prevented antibody binding, demonstrating that the staining observed was specific for HOCl-modified proteins (data not shown). Thus, our data suggest that, similarly to mammalian cells, HOCl-mediated cell death and oxidative stress in *S. cerevisiae* is associated with oxidation-dependent specific modifications.

HOCl elicits yeast cell death mainly through apoptosis
------------------------------------------------------

In order to characterize HOCl-induced cell death in *S. cerevisiae*, we examined a typical phenotypic feature of apoptotic cells: externalized phosphatidylserine at the outer leaflet of the plasma membrane, which binds to FITC-conjugated Annexin V and thus can be quantified. In parallel, we monitored a characteristic marker of necrosis, loss of membrane integrity, by assessing membrane permeability with propidium iodide (PI). By co-staining yeast cells with FITC-Annexin V and PI ([Fig. 1E](#F1){ref-type="fig"}), we were able to discriminate between early apoptosis (only Annexin V-stained cells), late apoptosis leading to secondary necrosis (double stained cells) and primary necrosis (only PI-stained cells).[@R15]^,^[@R16] Compared with the untreated wild type cells, yeast cells exposed to a physiologically relevant HOCl concentration (here 270 µM; see above) showed an increase of primarily apoptotic and more specifically late apoptotic cells, though a small rise in the primary necrotic population was also detectable ([Fig. 1E](#F1){ref-type="fig"}). This mainly apoptotic phenotype was further confirmed by TdT-mediated dUTP-biotin nick end labeling (TUNEL) staining, which revealed exacerbated apoptotic DNA fragmentation upon HOCl treatment ([Fig. 1F](#F1){ref-type="fig"}). In conclusion, HOCl cytotoxicity in yeast is mainly of apoptotic origin and only marginally involves primary necrosis.

Absence of the protease Kex1p but not of other lethal hydrolases partly reverts HOCl-induced cytotoxicity
---------------------------------------------------------------------------------------------------------

The knowledge about the mechanistic details accounting for HOCl-triggered cell death in yeast is only limited, even though it seems clear that oxidative damage represents a key component in the lethal process.[@R13] To gain further insights into the molecular regulators accounting for the execution of HOCl-induced cytotoxicity, we decided to determine loss of viability and ROS levels in the deletion background of genes encoding known apoptotic effectors, including the yeast metacaspase Yca1p,[@R17] the pro-apoptotic proteases Nma111p and Kex1p,[@R18]^,^[@R41] the yeast homologs of the human death regulators cathepsin D and calpain (Pep4p and Cpl1p),[@R22] the mitochondrial nuclease Nuc1p,[@R20] the yeast BH3-only protein Ybh3p[@R21] and the pro-apoptotic oxidoreductases Ndi1p and Aif1p.[@R42]^,^[@R43] Upon HOCl treatment, all disruptants except Δ*kex1* showed either no significant changes or even reduced cell viability in comparison to wild type cells ([Fig. 2A](#F2){ref-type="fig"}). Accordingly, ROS levels in these strains, except Δ*kex1*, remained either unchanged or were even increased as compared with the wild type control ([Fig. 2B](#F2){ref-type="fig"}). Thus, Kex1p (but not other hydrolases tested in this study) is required to execute the full cytotoxic activity of HOCl.

KEX1-disruption diminishes HOCl-mediated apoptosis and the formation of HOCl-modified epitopes
----------------------------------------------------------------------------------------------

Kex1p has been previously involved in yeast apoptotic scenarios.[@R41] To further characterize the rescuing effect of Δ*kex1* upon HOCl-stress, we analyzed if its improvement in cell viability and reduction in ROS production would correlate with a possible diminishment of apoptosis. Indeed, reduction of cell death ([Fig. 2C](#F2){ref-type="fig"}) and ROS generation ([Fig. 2D](#F2){ref-type="fig"}; [**Fig. S1A**](#SUP1){ref-type="supplementary-material"}) was accompanied by a specific and quantitatively similar decrease of the late apoptotic population as determined via Annexin V/PI co-staining ([Fig. 2E](#F2){ref-type="fig"}; [**Fig. S1B**](#SUP1){ref-type="supplementary-material"}). This was confirmed by TUNEL staining, which showed a corresponding decline of apoptotic DNA fragmentation in Δ*kex1* compared with the wild type control when stressed with HOCl ([Fig. 2F](#F2){ref-type="fig"}; [**Fig. S1C**](#SUP1){ref-type="supplementary-material"}). In addition, the formation of HOCl-modified epitopes, as detected via immunochemical techniques using the above mentioned specific antibody, was significantly reduced compared with wild type cells ([Fig. 2G](#F2){ref-type="fig"}, [**Fig. S1D**](#SUP1){ref-type="supplementary-material"}). Thus, Kex1p seems to promote HOCl-induced apoptosis apparently by acting upstream of ROS production and specific protein modification(s).

Discussion
==========

The present study aimed at establishing a cell death model for HOCl cytotoxicity, both to investigate its microbicidal effects and to model its cytotoxicity in mammalian cells. To this end, we used the eukaryotic unicellular fungus *S. cerevisiae* (budding yeast), which combines being (1) a microorganism and (2) an established model system to study PCD.[@R15]^,^[@R16] While the antimicrobial properties of phagocyte-generated HOCl have been known for some decades,[@R44]^,^[@R45] initial evidence for the cytotoxicity of HOCl in mammalian cells was provided by studies performed with activated neutrophils as well as the cell-free myeloperoxidase-hydrogen peroxide-chloride system.[@R8] Both inhibition of myeloperoxidase as well as scavenging of HOCl, added as reagent or generated by the myeloperoxidase-hydrogen peroxide-chloride system, confirmed that HOCl is responsible for impaired cell viability and cell death in various mammalian cell types.[@R8]^-^[@R10]^,^[@R46]^-^[@R49]

The results presented here characterize the cell death process occurring in *S. cerevisiae* upon exposure to lethal doses of HOCl. Previous reports have shown that budding yeast succumbs to cell death in response to chlorinative stress,[@R11]^,^[@R50] and that HOCl elicits cyto- and/or genotoxic effects against *S. cerevisiae*.[@R11]^-^[@R13] Further work has demonstrated that toxicity of HOCl in wild type yeast strains is abolished by hypoxic and anoxic conditions, and that antioxidant-deficient *S. cerevisiae* strains are more sensitive to treatment with oxychloro compounds, including HOCl.[@R13] In contrast to this earlier study, we more specifically monitored actual survival rates (via clonogenic tests), establishing a concentration-dependent deadly effect of HOCl on yeast. This cytotoxicity is accompanied by increased levels of ROS and can be counteracted by treatment with antioxidants, including glutathione. This confirms previous data showing elevated intracellular oxidative stress to be causative and the endogenous antioxidant system to be preventive during HOCl toxicity.[@R13]

Moreover, the present study defines the type of PCD induced by HOCl, which, according to our Annexin V/PI and TUNEL staining data, is mainly of apoptotic origin. However, a previous study[@R13] suggested necrosis to be the death type preferentially occurring in HOCl-treated yeast cells based on the absence of TUNEL- and the prominent presence of PI-positive cells. This discrepancy might be due to various reasons. First, different culture conditions were used; while our study was performed in minimal (SMD) medium, Kwolek-Mirek et al.[@R13] conducted theirs in complete (YEPD) medium, which differs in composition. This may have consequences for the extent and consequently type of toxicity (see below) at a particular concentration, especially given the high sensitivity of HOCl toxicity on slight media variance (see above). Second, the experiments performed with PI do not include a co-staining with an apoptotic stain like Annexin V that would allow discrimination between primary necrotic (PI^+^/Annexin V^−^) and late apoptotic (PI^+^/Annexin V^+^) cells, which both stain positive for PI. Thus, the authors[@R13] cannot exclude that part of the displayed PI positivity may actually correspond to a possible late apoptotic cell population. In fact, in our experiments, the main part of the stained population is late apoptotic and thus both PI- and Annexin V-positive. Third, the HOCl concentrations used in Kwolek-Mirek et al.[@R13] triggered PI staining of almost the complete yeast cell population, which raises the question whether the chosen toxic HOCl doses were too high to observe a putative apoptotic phenotype.

Indeed, HOCl may induce necrosis and/or apoptosis in a time- and concentration-dependent manner,[@R51]^,^[@R52] apparently via formation and decay of chloramines and generation of radical intermediates.[@R53]^,^[@R54] For instance, exposure to increasing doses of HOCl in endothelial cells induces cell death that progressively shifts from apoptosis to necrosis.[@R46] Similarly, many yeast cell death inducers known to cause apoptosis at moderate concentrations promote a necrotic phenotype when applied at higher doses.[@R16] The mere concentration increase of typical apoptotic triggers may, in most but not all cases, promote a non-regulated type of necrosis that likely arises from uncontrolled damage of cellular integrity. Thus, to test whether the necrotic phenotype displayed upon the high toxic HOCl dosage used in Kwolek-Mirek et al.[@R13] represents such accidental or alternatively programmed necrosis, experiments assaying for typical markers of programmed necrosis would need to be performed under their conditions. Irrespective of this discrepancy, which may have multifactorial causes, HOCl cytotoxicity in *S. cerevisiae* as induced in our hands is mainly linked to an apoptotic phenotype. This is in line with several processes that have been involved in HOCl-mediated cell death, including upregulation of pro-apoptotic genes,[@R50] downregulation of anti-apoptotic proteins[@R9] or DNA strand breakage.[@R55]

Intriguingly, HOCl-induced yeast apoptosis is accompanied by formation of HOCl-modified proteins. HOCl and/or chlorinated proteins/chloramines have been shown to trigger the apoptotic machinery in different human cell lines and seem to preferentially activate the mitochondrial apoptotic pathway.[@R49]^,^[@R56]^,^[@R57] Since the antibody used in this study to detect HOCl-modified epitopes in yeast also cross-reacts with HOCl-modified proteins occurring under inflammatory conditions in humans,[@R58] it is likely that similar epitopes are formed. We thus speculate that yeast and human cells share, at least in part, some molecular features of HOCl cytotoxicity. In this respect, follow-up studies will aim at identifying these modified proteins and elucidate their function in HOCl-triggered cell death execution.

While the induction of cell death by HOCl has been established in diverse cell types (human as well as microbial), the molecular players involved in each case remain elusive. Here, we aimed at identifying lethal hydrolases involved in HOCl-mediated yeast apoptosis. Interestingly, the single known yeast metacaspase Yca1p does not seem to represent the molecular executioner in this process. In contrast, HOCl cytotoxicity in mammalian cells has been linked to caspase activation.[@R46] Our data suggest, that---at least under conditions of fast proliferation and high glycolytic activity (represented by the model presented in this work)---HOCl exhibits its cytotoxicity through a caspase-independent mechanism. However, we also show that well-known caspase-independent effectors, such as the yeast homologs of endonuclease G (Nuc1p), BH3-only proteins (Ybh3p), the nuclear serine protease HtrA-like protein (Nma111p) or the apoptosis-inducing factor (Aif1p) are dispensable for HOCl-induced cytotoxicity. Instead, we identify the pro-apoptotic serine protease Kex1p as a pivotal factor in this process. Disruption of *KEX1* causes a decrease in clonogenic cell death, ROS production and the apoptotic population upon challenge with HOCl, while at the same time it diminishes the extent of HOCl-modified proteins.

Kex1p has been previously described to be a major player in Yca1p-independent yeast apoptotic cell death induced by protein N-glycosylation defects, where the production of ROS is a determinant factor for lethality.[@R41] Our results showing Kex1p-dependent increase of ROS production and formation of HOCl-modified proteins upon challenge with HOCl further suggest Kex1p as an executor of oxidation-mediated cytotoxicity. Thus, Kex1p-induced apoptosis seems to generally involve oxidative stress and possibly thereof resulting oxidized products, including modified proteins. HOCl-derived apoptosis could further comprise mechanistic elements present in cell death derived from defective protein N-glycosylation. At the same time, deletion of *KEX1* has also been shown to promote survival under different PCD-inducing conditions, namely acetic acid stress and chronological aging.[@R41] Thus, Kex1p may exert a more general role in yeast PCD. In that case, HOCl-mediated toxicity would not necessarily need to recapitulate upstream lethal pathways involved in N-glycosylation defects but would converge, possibly with other inducers, at the stage of Kex1p execution. Future work will have to clarify whether HOCl-induced cell death shares an upstream pathway with any of the above-mentioned lethal scenarios involving Kex1p.

By establishing the PCD mode in yeast upon challenge with HOCl and unveiling Kex1p as a molecular executor in this process, this study provides insight into the mechanisms underlying the microbicidal effects of HOCl toward fungal infections. However, these mechanisms might not correspond to those elicited during HOCl-induced killing of prokaryotes. In bacteria exposed to HOCl, the observed patterns of metabolic dysfunction suggest mechanisms where death occurs by interruption of the energy-transducing capabilities of the cell via inhibition of plasma membrane-localized proteins.[@R12] These patterns thus involve processes (like energy transduction or glucose transport) that differ from eukaryotic cells. This has previously put in doubt whether the microbicidal mechanisms of HOCl toxicity in *S. cerevisiae* mirror those observed in bacteria.[@R12] Interestingly, our results show that mitochondria seem to play a significant role in ROS-dependent HOCl lethality. Considering an evolutionary point of view, it would be interesting to explore whether mitochondrial membrane-localized proteins (similar to the situation in bacteria) are a target of HOCl. In addition, it has been recently shown that under certain circumstances, bacteria can succumb to an apoptotic-like cell death.[@R59]^-^[@R61] To which extent this or other forms of PCD might be involved in the bactericidal action of HOCl and how or if mitochondrial targeting in eukaryotes might recapitulate cytotoxic characteristics of HOCl in prokaryotes remains to be investigated.

In humans, activated phagocytic cells generate and release HOCl, a process, which (though firmly controlled) represents a major contributor to inflammatory tissue damage. Interestingly, several characteristics of HOCl-mediated yeast cell death described in this study, including ROS generation, mitochondrial involvement, an apoptotic phenotype and increased levels of HOCl-modified proteins, parallel already known features of HOCl-mediated cytotoxicity in humans.[@R8]^,^[@R10] Thus, our results also support the idea of employing *S. cerevisiae* as a model of HOCl-mediated cellular demise in human cells. In that respect, it will be interesting to test whether a similar protease, such as the herein identified yeast Kex1p, is involved in chlorinated protein-mediated apoptosis of inflamed human tissue. While there is no clear homolog of Kex1p in humans, the mammalian cathepsin A (like Kex1p a member of the serine protease group of hydrolases) shares about 20% overall similarity with Kex1p and represents a putative candidate for a factor involved in HOCl-induced apoptosis in human cells.

Summing up, this study establishes that the cytotoxic effect of HOCl on *S. cerevisiae* follows a Kex1p-dependent apoptotic pathway that possibly involves specific protein modifications reminiscent of those present in mammalian proteins upon HOCl stress. Whether or not these results compare with the situation in other eukaryotic and/or prokaryotic microorganisms needs further investigation. Similarly, future work will have to further address if budding yeast, in fact, represents a valid means to explore human HOCl-associated cellular demise, as the present study suggests.

Materials and Methods
=====================

Reagents
--------

The following reagents were purchased from the indicated suppliers: FITC-labeled Annexin V (Roche Applied Science, 11828681001), reagents for "terminal deoxynucleotidyl transferase dUTP nick end labeling" (TUNEL, Roche Applied Science, 11684795910), diyhdroethidium (DHE, Sigma-Aldrich, D7008), propidium iodide (PI, Sigma-Aldrich, P4170), L-glutathione (Sigma-Aldrich, G4251), N-acetyl- [L]{.smallcaps}-cysteine (Sigma-Aldrich, A9165) and sodium hypochlorite (NaOCl, Sigma-Aldrich, A7191). HOCl solutions were prepared immediately before use and the concentration was determined spectrophotometrically (ε~292~ 350 M^−^1 cm^−^1).

Yeast strains and growth conditions
-----------------------------------

Experiments were performed in wild type BY4741 and the respective *aif1*-, *nuc1*-, *yca1*-, *pep4*-,*nma111*-,*ndi1*-,*cpl1-*and*kex1-*null mutants, all obtained from Euroscarf. The strain BY4741 ρ0, previously described,[@R62]^,^[@R63] was used to analyze mitochondrial dependency. All experiments were performed in synthetic minimal medium (SMD) medium containing 0.17% yeast nitrogen base (Difco), 0.5% (NH~4~)~2~SO~4~ and 30 mg/l of all amino acids (except 80 mg/l histidine, 200 mg/l leucine), 30 mg/l adenine and 320 mg/l uracil with 2% glucose. Incubation of liquid cultures was performed with 145 rpm at 28°C. Cell densities were measured using an automated cell counter (CASY1, Roche Innovatis). As described in the results section, the quantitative degree of the cytotoxic effect elicited by HOCl seemed to be slightly dependent on the batch of SMD growth medium used. Thus, before using a new batch of medium, a concentration series was performed to determine the concentration range at which to carry out the subsequent experiments.

For all assays, overnight cultures of corresponding strains were inoculated in 45 ml SMD medium using 250 ml flasks (or---for the mini-screen as well as for experiments with L-glutathione and N-acetyl-L-cysteine--- inoculated in 15 ml using 100 ml flasks) at a density of 1.5 × 10^6^ cells/ml. Next, cells were grown to a cell density of 7--9 × 10^6^ cells/ml, subsequently distributed into 100 ml quadruple-indented flasks at 10 ml cell culture each (or--- for the mini-screen as well as for experiments with L-glutathione and N-acetyl-[L]{.smallcaps}-cysteine---into 96 deep-well plates at 250 µl cell culture medium each) and then either challenged with HOCl stock solution to reach the indicated final concentration or left untreated (control). Cells were incubated for 16 h after HOCl treatment and used for diverse assays. For experiments with antioxidants, cells were incubated with L-glutathione or N-acetyl-L-cysteine at indicated concentrations starting at the time of inoculation and thus prior to HOCl treatment.

Survival plating and tests for cell death markers
-------------------------------------------------

Clonogenic survival plating was performed as previously described.[@R17] Briefly, cell counts of HOCl-treated cultures and controls were measured; 500 cells were plated on YEPD agar plates and incubated for two days at 28°C to allow colony formation. The colony-forming units (CFUs) were analyzed using an automated colony counter (LemnaTech). For each strain, the CFUs determined for the control cultures were set to 100%, and the survival of the respective HOCl-treated cultures calculated relative to the corresponding control culture.

DHE staining (indicative for ROS production) was performed as described.[@R20]^,^[@R63] Briefly, 5 × 10^6^ cells were harvested by centrifugation, resuspended in 250 µl of 2.5 µg/ml DHE in PBS and incubated in the dark for 10 min. Relative fluorescence units (RFU) were determined by using a fluorescence reader (Tecan, GeniusPRO) and normalized to the OD~600~ of each sample. Alternatively, positive cells were counted using flow cytometry (BD FACSAria); 30,000 cells were used per experiment. Annexin V/PI costaining (apoptosis/necrosis marker) and TUNEL staining (apoptosis marker) were performed and quantified by flow cytometry as described.[@R20]^,^[@R22] 30,000 cells per sample were evaluated using BD FACSDiva software. Representative samples were subjected to qualitative analysis by fluorescence microscopy.

Immunofluorescence staining
---------------------------

For immunofluorescence studies, 1.5 × 10^7^ cells were fixed with 4% formaldehyde solution and their cell wall digested for 30 min with glucuronidase/arylsulfatase and lyticase as described.[@R20] After washing with sorbitol-containing buffer B \[35 mM potassium phosphate buffer (pH 6.8), 0.5 mM MgCl~2~ and 1.2 M Sorbitol\], cells were blocked with 100 µl blocking solution (Ultra V block, Thermo Fisher Scientific) for 20 min at 20°C. Cells were then spun down and the resulting pellets resuspended in 100 µl mAb antibody solution (clone 2D10G9, dilution 1:2, v/v in antibody diluent, Dako; 25°C for 30 min); the mAb recognizes HOCl-oxidized proteins, but does not cross-react with epitopes generated by oxidative reactions involving nitrating species, transition metals or lipid peroxidation reactions.[@R40] After washing once with sorbitol-containing buffer B, cells were incubated with 100 µl cyanine 3-conjugated goat anti-mouse antibody (Jackson Dianova, 1:300 in antibody diluent) for 20 min at 25°C. Fluorescence was microscopically evaluated and quantified using a fluorescence reader (Tecan, GeniusPRO). The obtained intensity was normalized to the OD~600~ of each sample.

Microscopy
----------

Microscopy was performed with a Zeiss Axioskop microscope using a Zeiss Plan-Neofluar objective lense with 100× magnification and 1.30 numerical aperture in oil (using Zeiss Immersol^®^) at room temperature. Imaging medium was AnnexinV/PI incubation buffer (10 mM HEPES, 140 mM NaCl, 5 mM CaCl~2~ pH 7.4) + 0.6 M sorbitol for pictures shown in [**Figure S1B**](#SUP1){ref-type="supplementary-material"} and water for pictures shown in [Figures 1F](#F1){ref-type="fig"} and [**Figure. S1A, C and D**](#SUP1){ref-type="supplementary-material"}. Fluorochromes were fluorescein (used as fluorescein isothiocyanate, FITC), propidium iodide (PI) and ethidium (after conversion from dihydroethidium, DHE) for pictures shown in [**Figure S1A--C**](#SUP1){ref-type="supplementary-material"}. Fluorescence microscopic sample images were taken with a Diagnostic Instruments camera (Model: SPOT 9.0 Monochrome-6), acquired using the Metamorph software (version 6.2r4, Universal Imaging Corp.) and processed with Adobe Photoshop (version CS2) software. Specifically, picture processing involved creation of AnnexinV and PI overlays in [**Figure S1B**](#SUP1){ref-type="supplementary-material"} and coloring ([Figs. 1F](#F1){ref-type="fig"}; [**Fig. S1A--D**](#SUP1){ref-type="supplementary-material"}) with Metamorph. In addition, contrast and brightness was adjusted with Adobe Photoshop (applying equal adjustment parameters to all pictures of an experiment).

Statistical analyses
--------------------

Error bars (± s.e.m.) are shown for independent experiments. When experiments were performed in parallel, a common overnight culture and common pre-cultures were used for each strain. In these cases, pre-cultures were divided into separate flasks (or wells in the mini-screen) prior to HOCl stress. The number of independent data points (n) is indicated in the figure legends of the corresponding graphs. Significances were calculated using an ANOVA approach and were corrected by the Bonferroni post hoc test.
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CFU

:   colony-forming units

DHE

:   dihydroethidium

Eth

:   ethidium

FITC

:   fluorescein isothiocyanate

HOCl/OCl^-^

:   hypochlorous acid/hypochlorite

PCD

:   programmed cell death

PI

:   propidium iodide

ROS

:   reactive oxygen species *S. cerevisiae*, *Saccharomyces cerevisiae*
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